ELUMASSIST

Alkermes Pharma Ireland Limited

Application Filed: 2018-06-26
Trademark Application Details
Trademark Logo ELUMASSIST

Mark For: ELUMASSIST™ trademark registration is intended to cover the categories of health care and medical information services in the field of support program for patients, patient families and caregivers in the administration of pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar disorder and cyclothymic disorder, anxiety, post-traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder. [all]

Status

2021-07-21 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88015199
Mark Literal ElementsELUMASSIST
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeSERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-05-14
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 044 - Primary Class
  • (Medical, beauty & agricultural) Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameNorm J. Rich
Attorney Docket Number029318-2795
Law Office AssignedL90
Employee NameANKRAH, NAAKWAMA S

Timeline

2018-06-26Application Filed
2019-02-11Location: PUBLICATION AND ISSUE SECTION
2019-02-11Status: Live/Pending
2019-02-11Transaction Date
2019-03-19Published
2019-03-19Published for Opposition
2019-05-14Location: INTENT TO USE SECTION
2021-04-13Status: A fourth request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Alkermes Pharma Ireland Limited
AddressCONNAUGHT HOUSE 1 Burlington Road Dublin IRELAND
Legal Entity TypeCorporation
Legal Entity StateIRELAND

Documents

DrawingJPEG2018-06-26
TEAS RF New ApplicationMULTI2018-06-26
Offc Action OutgoingAPPLICATION/XML2018-10-17
XSearch Search SummaryXML2018-10-17
Response to Office ActionAPPLICATION/XML2019-01-24
Amendment and Mail Process CompleteMULTI2019-01-26
TRAM Snapshot of App at Pub for OppostnMULTI2019-01-29
Notice of PublicationAPPLICATION/XML2019-02-27
OG Publication ConfirmationXML2019-03-19
Notice of AllowanceXML2019-05-14
Extension of Time to File SOUAPPLICATION/XML,IMAGE/JPEG2019-10-17
ITU Extension ApprovalAPPLICATION/XML2019-10-19
ITU Unit ActionMULTI2019-10-19
Extension of Time to File SOUAPPLICATION/XML2020-04-22
ITU Extension ApprovalXML2020-04-24
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-04-24
Extension of Time to File SOUXML2020-10-29
ITU Extension ApprovalAPPLICATION/XML2020-10-31
ITU Unit ActionMULTI2020-11-02
Extension of Time to File SOUAPPLICATION/XML2021-04-13
ITU Extension ApprovalXML2021-04-15
ITU Unit ActionMULTI2021-04-15

Attorney of Record

NORM J. RICH
FOLEY & LARDNER LLP
3000 K STREET, N.W.
SIXTH FLOOR
WASHINGTON, DC 20007

Good, Services, and Codes


IC 044. US 100 101. G & S: Health care and medical information services in the field of support program for patients, patient families and caregivers in the administration of pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar disorder and cyclothymic disorder, anxiety, post-traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder

International Codes:44
U.S. Codes:100,101
Type CodeType
PM0001ELUM ASSIST

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-04-15
TEAS EXTENSION RECEIVED2021-04-13
EXTENSION 4 GRANTED2021-04-1398765
EXTENSION 4 FILED2021-04-1398765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-10-31
TEAS EXTENSION RECEIVED2020-10-29
EXTENSION 3 GRANTED2020-10-2998765
EXTENSION 3 FILED2020-10-2998765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-04-24
TEAS EXTENSION RECEIVED2020-04-22
EXTENSION 2 GRANTED2020-04-2298765
EXTENSION 2 FILED2020-04-2298765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-10-19
TEAS EXTENSION RECEIVED2019-10-17
EXTENSION 1 GRANTED2019-10-1798765
EXTENSION 1 FILED2019-10-1798765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-05-14
PUBLISHED FOR OPPOSITION2019-03-19
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-03-19
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-02-27
ASSIGNED TO LIE2019-02-1170884
APPROVED FOR PUB - PRINCIPAL REGISTER2019-01-26
TEAS/EMAIL CORRESPONDENCE ENTERED2019-01-2588889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-01-24
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-01-2488889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-10-176325
NON-FINAL ACTION WRITTEN2018-10-1776833
NON-FINAL ACTION E-MAILED2018-10-176325
ASSIGNED TO EXAMINER2018-10-1676833
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-06-30
NEW APPLICATION ENTERED IN TRAM2018-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed